1. 智能化融合:发展数据挖掘、集成、分析、可视化及人工智能工具,实现数据与文献、模型、计算等资源的有机融合,促进领域数智驱动科研新范式变革.
2. 标准化体系建设:以统一的数据标准管理体系为基础,系统整合全链条多源异构数据,聚焦高价值业务需求,精准构建结构合理、标注规范、语义清晰的数据资源.
3. 开放共享生态:开展数据提供方、使用方和服务方生态体系建设,实现多元主体间数据共享、共用、共治。.
4. 多模态数据处理:构建“全模态数据治理平台+高质量数据服务”一体化解决方案,提升非结构化数据处理能力.

Cefditoren Pivoxil is a semi-synthetic, broad-spectrum, beta-lactamase resistant, third-generation cephalosporin antibiotic with bactericidal activity. Cefditoren pivoxil is a prodrug that is rapidly ...
Sakagami, Kenji; Atsumi, Kunio; Yamamoto, Yuichi; Tamura, Atsuhi; Yoshida, Takashi; Nishihata, Ken; Fukatsu, Shunzo. Synthesis and oral activity of pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3(Z)-(4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylate (ME1207) and its related compound. Chemical & Pharmaceutical Bulletin. Pharm. Res. Cent. Meiji Seika Kaisha, Ltd. Yokohama, Japan 222. Volume 39. Issue 9. Pages 2433-6. 1991
Nebivolol is a β1 receptor blocker with nitric oxide-potentiating vasodilatory effect used in treatment of hypertension and, in Europe, also for left ventricular failure. It is highly cardioselective...
Sheth, Rakesh; Attanti, Srinivasarao Veeravenkata; Patel, Hasmukh Mathurbhai; Gupta, Vinodkumar; Nadkarni, Sunil Sadanand. Process for preparation of Nebivolol from 6-fluoro-3,4-dihydro-α-[[(phenylmethyl)amino]methyl]-2H-1-benzopyran-2-methanol and 6-fluoro-3,4-dihydro-2-oxiranyl-2H-benzopyran. Assignee Torrent Pharmaceuticals Limited, India. WO 2006025070. (2006).
Omidenepag isopropyl is a novel, selective, non-prostanoid EP2 receptor agonist. It can be used for treatment of open-angle glaucoma and ocular hypertension. Omidenepag isopropyl is a prodrug that is ...
This synthetic route was from WO2009113600.
Baricitinib, also known as INCB028050 or LY3009104, is a selective orally bioavailable JAK1/JAK2 inhibitor with nanomolar potency against JAK1 (5.9 nM) and JAK2 (5.7 nM). INCB028050 inhibits intracell...
Reference: Xu, Jiaojiao; Cai, Jin; Chen, Junding; Zong, Xi; Wu, Xuan; Ji, Min; Wang, Peng. An efficient synthesis of baricitinib. Journal of Chemical Research. Volume 40. Issue 4. Pages 205-208. Journal. (2016).
Levacetylleucine (N-acetyl-L-leucine, NALL) has demonstrated both cellular and animal bioactivity consistent with neuroprotective and lysosome-modulating effects. In vitro, NALL induces nuclear transl...
Preprogramming Complex Hydrogel Responses using Enzymatic Reaction NetworksBy: Postma, Sjoerd G. J.; et alAngewandte Chemie, International Edition (2017), 56(7), 1794-1798
Carglumic acid is an orphan drug, marketed by Orphan Europe under the trade name Carbaglu. Carglumic acid is used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase defic...
Verardo, Giancarlo; Geatti, Paola; Strazzolini, Paolo Synthetic Communications Volume 37 Issue 11 Pages 1833-1844 Journal 2007
Sofosbuvir, also known as PSI-7977 and GS7977 (brand names Sovaldi and Virunon), is a drug used for hepatitis C virus (HCV) infection, with a high cure rate. It inhibits the RNA polymerase that the he...
Reference: Wilhelm, Thorsten; Schoene, Olga. Synthesis of sofosbuvir nucleoside phosphoramidate via hydride reduction of ketone. WO 2018134343. (Sandoz AG, Switz)
Vibegron, also known as MK-4618, is a potent and selective Beta 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder (OAB). Vibegron has no unacceptable toxicity in preclinical speci...
Highly diastereoselective total synthesis of Vibegron, a drug for overactive bladder diseaseBy: Adarsh, D. R.; et alTetrahedron Letters (2025), 155, 155429
Acanthoic acid is a pimaradiene diterpene isolated from Acanthopanax koreanum. It has been reported to have anti-inflammatory activities. Acanthoic acid downregulates LPS-induced TNF-α, IL-6 and IL-1β...
Enantioselective Synthesis of the Antiinflammatory Agent (-)-Acanthoic AcidBy: Ling, Taotao; et alJournal of Organic Chemistry (2001), 66(26), 8843-8853
Fruquintinib, also known as HMPL-013, is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activ...
Patent#: CN112724110
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
